ERA - Leading European Nephrology

My ERA ERA beitreten

Home | Video pages | Webcast | Calcification propensity: from biomarker to treatment target?

Calcification propensity: from biomarker to treatment target?

Teilen

https://www.youtube.com/watch?v=LrR-sHWYnuQ kopieren

Other e-seminars from CKD-MBD & EuReCa-M

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

AKI to CKD transition

A 70-year-old man with CKD G4, osteoporosis and low bone turnover

Endocrine functions of the bone and their potential contributions to systemic CKD complications

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

A patient with CKD and an atypical bone fracture after long-term use of bisphosphonates

The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

A patient with muscle weakness and hypophosphatemia

CKD-MBD: from bone biopsy to treatment in advanced CKD patients not vice versa

A patient on dialysis with a vertebral fracture and low BMD

Heart failure in patients with CKD: diagnosis and therapeutic approaches

Crosstalk between bone and the vasculature in diabetes and CKD